Venaxis, Inc.
8100 Southpark Way
Unit B-1
Littleton
Colorado
80120
United States
Tel: 303-794-2000
Fax: 303-798-8332
Website: http://www.venaxis.com/
184 articles about Venaxis, Inc.
-
Venaxis Reports Name Change To BiOptix And NASDAQ Ticker Symbol Change To "BIOP" From "APPY"
12/9/2016
-
Venaxis Reports Option Inducement Grants For New Employees Under NASDAQ Listing Rule 5635(C)(4)
9/23/2016
-
Venaxis Announces Acquisition Of BiOptix
9/14/2016
-
Strand Life Sciences, Venaxis Terminate Merger Plans
3/15/2016
-
Venaxis, Inc. Announces Transaction With Strand Life Sciences
1/27/2016
-
Venaxis, Inc. Business Update
6/22/2015
-
Venaxis, Inc. To Provide Business Update
4/7/2015
-
Venaxis, Inc. Business Update
2/12/2015
-
FDA Denies Venaxis, Inc.'s Appendicitis Test 510(k) Submission
1/29/2015
-
Venaxis, Inc. To Present At Biotech Showcase™ 2015
1/7/2015
-
Venaxis, Inc. Files Response To FDA's Request For Additional Information
12/4/2014
-
Venaxis, Inc. To Present At Canaccord Genuity 2014 Medical Technologies & Diagnostics Forum
11/14/2014
-
Venaxis, Inc.' APPY1 Trial Results Presented By Dr. David S. Huckins, M.D., At ACEP14
10/28/2014
-
Venaxis, Inc. Announces APPY1 Test Clinical Trial Results To Be Presented At ACEP14
10/15/2014
-
Venaxis, Inc. To Present At September Investor Conferences
8/28/2014
-
Venaxis, Inc. Announces Regulatory And Market Development Progress
8/11/2014
-
Venaxis, Inc. To Provide Business Update, Including FDA Submission Update
8/8/2014
-
Venaxis, Inc. To Present At Canaccord Genuity 34th Annual Growth Conference
8/6/2014
-
Venaxis, Inc. Reports On Recent FDA Submission Activities
7/16/2014
-
Venaxis, Inc. To Present At ICV Company Outreach Summit
7/2/2014